ELOVL4 antibody (C-Term)
Quick Overview for ELOVL4 antibody (C-Term) (ABIN952069)
Target
See all ELOVL4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 285-314, C-Term
-
Specificity
- This antibody recognizes Human ELOVL4 (C-term).
-
Purification
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 285-314 amino acids from the C-terminal region of Human ELOVL4.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))
-
Alternative Name
- ELOVL4
-
Background
- ELOVL4 is a membrane-bound protein which is a member of the ELO family, proteins which participate in the biosynthesis of fatty acids. Consistent with the expression of the encoded protein in photoreceptor cells of the retina, mutations and small deletions in this gene are associated with Stargardt-like macular dystrophy (STGD3) and autosomal dominant Stargardt-like macular dystrophy (ADMD), also referred to as autosomal dominant atrophic macular degeneration.Synonyms: 3-keto acyl-CoA synthase ELOVL4, Elongation of very long chain fatty acids protein 4
-
Molecular Weight
- 36829 Da
-
Gene ID
- 6785
-
NCBI Accession
- NP_073563
Target
-